- Business
- MatsukiyoCocokara & Co. (ticker: MSMKF), founded in 1932 through predecessor entities and headquartered in Tokyo, Japan, operates as Japan's leading health and beauty retailer, managing over 3,400 drugstores, insurance-dispensing pharmacies and franchise outlets nationwide through segments including the Matsumotokiyoshi Group Business, Cocokara Fine Group Business and Management Support Business. The company retails pharmaceuticals, over-the-counter medications, prescription drugs, cosmetics, beauty care products, health foods, personal care items, supplements, household necessities and private brand goods; it also provides wholesale distribution of medicines and daily goods to retailers and healthcare providers, franchise development and support services encompassing IT infrastructure, human resources, finance, marketing, advertising, promotion, asset management, store construction and insurance agency operations. Operations span Japan with overseas expansion in Asia including 79 stores in Singapore, Macao and Malaysia as of March 2025, targeting ASEAN markets and inbound travelers through proprietary brands and services such as MatsukiyoCocokara Q store-to-home delivery, MatsukiyoCocokara Me digital pharmacy app, MatsukiyoCocokara Be EC beauty platform with makeup simulation and skin/hair assessments, MatsukiyoCocokara Up personalized supplement subscriptions and on-demand delivery using electric vehicles. In October 2021, the company changed its trade name from Matsumotokiyoshi Holdings Co., Ltd. following the management integration with cocokara fine Inc., achieving merger synergies of 30 billion yen and surpassing prior medium-term targets early with FY2024 net sales of 1,061.6 billion yen, operating profit margin of 7.7% and ROE of 10.6%. On May 9, 2025, MatsukiyoCocokara unveiled a new medium-term management plan through FY2030 emphasizing co-creating value via differentiation through platform enhancements like one-to-one marketing and 45 million registered customers, investments totaling around 160 billion yen in store openings/renovations, IT/digital transformation, small-to-medium M&As, alliances, human capital, overseas growth aiming for 100 billion yen in overseas sales and carbon neutrality initiatives, alongside 45% cash allocation to growth and shareholder returns targeting 50% dividend payout, 6% DOE and ROE over 12%.